# Pembrolizumab‐induced secondary sclerosing cholangitis in a non‐small cell lung cancer patient

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/pembrolizumab-induced-secondary-sclerosing-cholangitis-in-a-non-small-cell-lung/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Sachiko Matsumoto,Keisuke Watanabe,Nobuaki Kobayashi,Kuniyasu Irie,Shoji Yamanaka,Takeshi Kaneko |
| Citations | 16 |
| DOI | 10.1002/rcr2.560 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/rcr2.560 |
| OpenAlex ID | https://openalex.org/W3015471622 |
| PMID | 32284868 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Kuniyasu Irie](https://scholariq.org/researchers/kuniyasu-irie/)

## Paper journal

- [Respirology Case Reports](https://scholariq.org/journals/respirology-case-reports/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis](https://scholariq.org/topics/interstitial-lung-diseases-and-idiopathic-pulmonary-fibrosis/)
- [Liver Diseases and Immunity](https://scholariq.org/topics/liver-diseases-and-immunity/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.